{"id":22336,"date":"2023-02-16T10:17:29","date_gmt":"2023-02-16T18:17:29","guid":{"rendered":"https:\/\/ameripharmaspecialty.com\/?p=22336"},"modified":"2026-03-20T14:32:13","modified_gmt":"2026-03-20T21:32:13","slug":"zirabev","status":"publish","type":"post","link":"https:\/\/ameripharmaspecialty.com\/es\/cancer\/zirabev\/","title":{"rendered":"Zirabev: \u00bfQu\u00e9 es y c\u00f3mo funciona?"},"content":{"rendered":"<p><span style=\"font-weight: 400;\">Zirabev es un f\u00e1rmaco anticancer\u00edgeno con un componente activo, &quot;bevacizumab-bvzr&quot;. Se utiliza para tratar varios tipos de c\u00e1ncer y pertenece a la clase de inhibidores del factor de crecimiento endotelial vascular (VEGF), que atacan las prote\u00ednas VEGF y bloquean su actividad. En pacientes con c\u00e1ncer, las prote\u00ednas VEGF se sobreexpresan y suelen participar en la formaci\u00f3n de nuevos vasos sangu\u00edneos dentro de las c\u00e9lulas cancerosas para proporcionarles ox\u00edgeno y otros nutrientes necesarios para su crecimiento y divisi\u00f3n celular.&nbsp;<\/span><\/p>\n\n\n\n<div  id=\"call-to-action-4304b8ed01fee42ed84905c86152faaf\" style=\"\" class=\"ct_call_to_action\">\n\t<div class=\"container\">\n\t\t<div class=\"block-wrap cta\">\n\t\t\t<div class=\"block-column\">\n\t\t\t\t<div class=\"cta_headings\">\n\t\t\t\t\t\t\t\t\t\t\t<h4 class=\"cta__heading\">\n\t\t\t\t\t\t\tObtenga asistencia para el copago Zirabev\t\t\t\t\t\t<\/h4>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"cta__sub__heading\">\n\t\t\t\t\t\t\tHabla con un especialista\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<span class=\"cta_btn\">\n\t\t\t\t\t\t<a href=\"tel:8777780318\">(877) 778-0318<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t<\/div>\n\n\t\t<\/div>\n\t<\/div>\n<\/div>\n\n\n\n<p><span style=\"font-weight: 400;\">En 2019, el <a href=\"https:\/\/www.fda.gov\/\">FDA<\/a> aprob\u00f3 Zirabev como una versi\u00f3n biosimilar de <a href=\"http:\/\/Avastin\">Avastin<\/a> (un f\u00e1rmaco biol\u00f3gico ya autorizado por la FDA) ya que contiene la sustancia activa, \u201cbevacizumab\u201d. En comparaci\u00f3n con Avastin, ofrece la misma eficacia, funciona de la misma manera y presenta los mismos efectos secundarios.\u00a0<\/span><\/p>\n\n\n\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_82_2 counter-hierarchy ez-toc-counter ez-toc-custom ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Alternar tabla de contenido\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Palanca<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewbox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewbox=\"0 0 24 24\" version=\"1.2\" baseprofile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/ameripharmaspecialty.com\/es\/cancer\/zirabev\/#What_Is_Zirabev_Used_To_Treat\" >\u00bfPara qu\u00e9 se utiliza el Zirabev?<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/ameripharmaspecialty.com\/es\/cancer\/zirabev\/#Metastatic_Colorectal_Cancer_mCRC\" >C\u00e1ncer colorrectal metast\u00e1sico (CCRm)<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/ameripharmaspecialty.com\/es\/cancer\/zirabev\/#Metastatic_Renal_Cell_Carcinoma_mRCC\" >Carcinoma de c\u00e9lulas renales metast\u00e1sico (CCRm)<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/ameripharmaspecialty.com\/es\/cancer\/zirabev\/#Ovarian_Cancer\" >C\u00e1ncer de ovario<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/ameripharmaspecialty.com\/es\/cancer\/zirabev\/#Metastatic_Cervical_Cancer\" >C\u00e1ncer de cuello uterino metast\u00e1sico<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/ameripharmaspecialty.com\/es\/cancer\/zirabev\/#Non-squamous_Non-small_Cell_Lung_Cancer\" >C\u00e1ncer de pulm\u00f3n de c\u00e9lulas no peque\u00f1as y no escamosas<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/ameripharmaspecialty.com\/es\/cancer\/zirabev\/#Recurrent_Glioblastoma\" >Glioblastoma recurrente<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/ameripharmaspecialty.com\/es\/cancer\/zirabev\/#How_Does_Zirabev_Work\" >\u00bfC\u00f3mo funciona Zirabev?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/ameripharmaspecialty.com\/es\/cancer\/zirabev\/#Dosage_Form_and_Strength\" >Forma farmac\u00e9utica y concentraci\u00f3n<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/ameripharmaspecialty.com\/es\/cancer\/zirabev\/#Zirabev_Dosing_Information\" >Informaci\u00f3n de dosificaci\u00f3n del Zirabev<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/ameripharmaspecialty.com\/es\/cancer\/zirabev\/#For_Metastatic_Colorectal_Cancer_mCRC\" >Para el c\u00e1ncer colorrectal metast\u00e1sico (CCRm)<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/ameripharmaspecialty.com\/es\/cancer\/zirabev\/#For_Metastatic_Renal_Cancer\" >Para el c\u00e1ncer renal metast\u00e1sico<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/ameripharmaspecialty.com\/es\/cancer\/zirabev\/#For_Metastatic_Cervical_Cancer\" >Para el c\u00e1ncer de cuello uterino metast\u00e1sico<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/ameripharmaspecialty.com\/es\/cancer\/zirabev\/#For_Ovarian_Cancer\" >Para el c\u00e1ncer de ovario<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/ameripharmaspecialty.com\/es\/cancer\/zirabev\/#For_Recurrent_Glioblastoma\" >Para el glioblastoma recurrente<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/ameripharmaspecialty.com\/es\/cancer\/zirabev\/#For_Non-squamous_Non-small_Cell_Lung_Cancer\" >Para el c\u00e1ncer de pulm\u00f3n de c\u00e9lulas no peque\u00f1as y no escamosas<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/ameripharmaspecialty.com\/es\/cancer\/zirabev\/#How_Is_Zirabev_Given\" >\u00bfC\u00f3mo se administra Zirabev?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/ameripharmaspecialty.com\/es\/cancer\/zirabev\/#Is_Zirabev_a_Chemotherapy_Drug\" >\u00bfEs Zirabev un f\u00e1rmaco de quimioterapia?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/ameripharmaspecialty.com\/es\/cancer\/zirabev\/#Possible_Side_Effects_of_Zirabev\" >Posibles efectos secundarios de Zirabev<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-20\" href=\"https:\/\/ameripharmaspecialty.com\/es\/cancer\/zirabev\/#Zirabev_Precautions\" >Precauciones del Zirabev<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-21\" href=\"https:\/\/ameripharmaspecialty.com\/es\/cancer\/zirabev\/#Zirabev_Cost\" >Costo del Zirabev&nbsp;<\/a><\/li><\/ul><\/nav><\/div>\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"What_Is_Zirabev_Used_To_Treat\"><\/span>\u00bfPara qu\u00e9 se utiliza el Zirabev?<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p><span style=\"font-weight: 400;\">Zirabev se utiliza para tratar seis tipos de formas avanzadas de c\u00e1ncer con las siguientes caracter\u00edsticas:<\/span><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><span style=\"font-weight: 400;\">C\u00e1ncer que se ha propagado a otras \u00e1reas o que no ha respondido o no ha sido tratado bien previamente<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">C\u00e1ncer que reaparece (regresa) o empeora despu\u00e9s de un tratamiento previo<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">C\u00e1ncer que no se puede extirpar con cirug\u00eda<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">C\u00e1ncer resistente a la quimioterapia basada en platino<\/span><\/li>\n<\/ul>\n\n\n\n<p><span style=\"font-weight: 400;\">Dependiendo del estadio del c\u00e1ncer y del fracaso del tratamiento previo, Zirabev puede utilizarse como terapia de agente \u00fanico o, en algunos casos, combinarse con agentes de quimioterapia.&nbsp;<\/span><\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Metastatic_Colorectal_Cancer_mCRC\"><\/span>C\u00e1ncer colorrectal metast\u00e1sico (CCRm)<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p><span style=\"font-weight: 400;\">El c\u00e1ncer colorrectal metast\u00e1sico es una forma avanzada de c\u00e1ncer que se origin\u00f3 en el colon o el recto, pero se ha propagado a otras zonas del cuerpo. Si el paciente no ha recibido tratamiento previo, se utiliza Zirabev como tratamiento de primera l\u00ednea en combinaci\u00f3n con quimioterapia basada en fluorouracilo.&nbsp;<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">En otros casos, si el paciente ha sido tratado previamente con bevacizumab (Zirabev, Avastin o <a href=\"https:\/\/ameripharmaspecialty.com\/es\/mvasi-copay-assistance\/\">Mvasi<\/a>), y su c\u00e1ncer no respondi\u00f3 bien, se utiliza entonces Zirabev como tratamiento de segunda l\u00ednea en combinaci\u00f3n con quimioterapia.&nbsp;<\/span><\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Metastatic_Renal_Cell_Carcinoma_mRCC\"><\/span>Carcinoma de c\u00e9lulas renales metast\u00e1sico (CCRm)<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p><span style=\"font-weight: 400;\">Zirabev se utiliza en combinaci\u00f3n con interfer\u00f3n alfa para tratar a pacientes con c\u00e1ncer renal metast\u00e1sico (c\u00e1ncer de ri\u00f1\u00f3n que se ha diseminado a otras \u00e1reas).&nbsp;<\/span><\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Ovarian_Cancer\"><\/span>C\u00e1ncer de ovario<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p><span style=\"font-weight: 400;\">El c\u00e1ncer de ovario representa un grupo de c\u00e1ncer que comienza en los ovarios de las mujeres y se propaga a otras \u00e1reas, como las trompas de Falopio y <\/span><span style=\"font-weight: 400;\">el peritoneo.&nbsp;<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">Los pacientes con este c\u00e1ncer generalmente reciben tratamiento con Zirabev en combinaci\u00f3n con medicamentos de quimioterapia (paclitaxel y carboplatino), seguido de Zirabev solo.&nbsp;<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">Si el c\u00e1ncer de un paciente es sensible a la quimioterapia basada en platino o regresa despu\u00e9s de seis meses, primero se utiliza Zirabev en combinaci\u00f3n con agentes de quimioterapia (paraplatino y paclitaxel o gemcitabina), seguido de Zirabev como terapia de agente \u00fanico.&nbsp;<\/span><\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Metastatic_Cervical_Cancer\"><\/span>C\u00e1ncer de cuello uterino metast\u00e1sico<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p><span style=\"font-weight: 400;\">En este c\u00e1ncer, Zirabev se utiliza en combinaci\u00f3n con agentes de quimioterapia (topotec\u00e1n y paclitaxel o cisplatino y paclitaxel).&nbsp;<\/span><\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Non-squamous_Non-small_Cell_Lung_Cancer\"><\/span>C\u00e1ncer de pulm\u00f3n de c\u00e9lulas no peque\u00f1as y no escamosas<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p><span style=\"font-weight: 400;\">Zirabev se utiliza como tratamiento de primera l\u00ednea combinado con agentes de quimioterapia (paclitaxel y carboplatino) en pacientes cuyo tumor es metast\u00e1sico, persistente e irresecable (el c\u00e1ncer no se puede extirpar mediante cirug\u00eda).&nbsp;<\/span><\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Recurrent_Glioblastoma\"><\/span>Glioblastoma recurrente<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p><span style=\"font-weight: 400;\">Zirabev se utiliza como agente \u00fanico para tratar <a href=\"https:\/\/www.aans.org\/en\/Patients\/Neurosurgical-Conditions-and-Treatments\/Glioblastoma-Multiforme\">glioblastoma<\/a>, una forma agresiva de c\u00e1ncer de cerebro y m\u00e9dula espinal.&nbsp;<\/span><\/p>\n\n\n\n<div  id=\"call-to-action-104e23292324b4914797eb059ae54f84\" style=\"\" class=\"ct_call_to_action\">\n\t<div class=\"container\">\n\t\t<div class=\"block-wrap cta\">\n\t\t\t<div class=\"block-column\">\n\t\t\t\t<div class=\"cta_headings\">\n\t\t\t\t\t\t\t\t\t\t\t<h4 class=\"cta__heading\">\n\t\t\t\t\t\t\tObtenga asistencia para el copago\t\t\t\t\t\t<\/h4>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"cta__sub__heading\">\n\t\t\t\t\t\t\tZirabev Asistencia financiera\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<span class=\"cta_btn\">\n\t\t\t\t\t\t<a href=\"#form\">Programar una consulta<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t<\/div>\n\n\t\t<\/div>\n\t<\/div>\n<\/div>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"How_Does_Zirabev_Work\"><\/span>\u00bfC\u00f3mo funciona Zirabev?<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p><span style=\"font-weight: 400;\">El Zirabev act\u00faa para ralentizar el crecimiento de los c\u00e1nceres. Contiene un componente activo, \u201cbevacizumab-bvzr\u201d, que es un anticuerpo monoclonal recombinante (IgG1) dise\u00f1ado para reconocer y unirse a <\/span><span style=\"font-weight: 400;\">Prote\u00ednas VEGF (que normalmente estimulan la formaci\u00f3n de vasos sangu\u00edneos para proporcionar al c\u00e1ncer nutrientes esenciales para crecer y dividirse).<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">Al unirse a la prote\u00edna VEGF, inhibe su actividad. Como resultado, los vasos sangu\u00edneos no crecen dentro de las c\u00e9lulas cancerosas. Debido a la falta de nutrientes y ox\u00edgeno, las c\u00e9lulas cancerosas se mueren de hambre y no progresan.<\/span><\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Dosage_Form_and_Strength\"><\/span>Forma farmac\u00e9utica y concentraci\u00f3n<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p><span style=\"font-weight: 400;\">El Zirabev se presenta en un vial monodosis de administraci\u00f3n intravenosa. Este vial monodosis est\u00e1 disponible en:<\/span><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><span style=\"font-weight: 400;\">Concentraci\u00f3n de 100 mg\/4 ml (contiene 25 mg de bevacizumab-bvzr\/ml)&nbsp;<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Concentraci\u00f3n de 400 mg\/16 ml (contiene 25 mg de bevacizumab-bvzr\/ml)<\/span><\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Zirabev_Dosing_Information\"><\/span>Informaci\u00f3n de dosificaci\u00f3n del Zirabev<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p><span style=\"font-weight: 400;\">Las dosis se establecen seg\u00fan el tipo de c\u00e1ncer a tratar y el peso corporal actual. Las dosis recomendadas por la FDA son las siguientes:<\/span><\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"For_Metastatic_Colorectal_Cancer_mCRC\"><\/span>Para el c\u00e1ncer colorrectal metast\u00e1sico (CCRm)<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p><span style=\"font-weight: 400;\">Los pacientes que padecen CCRm deben tomar las siguientes dosis de Zirabev en combinaci\u00f3n con quimioterapia intravenosa basada en fluorouracilo:<\/span><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><span style=\"font-weight: 400;\">5 mg\/kg cada dos semanas en combinaci\u00f3n con <\/span><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/16835478\/\"><span style=\"font-weight: 400;\">bolo-IFL<\/span><\/a><span style=\"font-weight: 400;\">.&nbsp;<\/span><\/li>\n<\/ul>\n\n\n\n<ul class=\"wp-block-list\">\n<li><span style=\"font-weight: 400;\">10 mg\/kg cada dos semanas en combinaci\u00f3n con <\/span><a href=\"https:\/\/www.cancer.gov\/publications\/dictionaries\/cancer-terms\/def\/folfox-4\"><span style=\"font-weight: 400;\">FOLFOX4<\/span><\/a><span style=\"font-weight: 400;\">.&nbsp;<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Para un paciente que mostr\u00f3 progreso con un r\u00e9gimen que contiene un producto bevacizumab, 5 mg\/kg cada 2 semanas o 7,5 mg\/kg cada 3 semanas en combinaci\u00f3n con quimioterapia basada en fluoropirimidina-irinotec\u00e1n o fluoropirimidina-oxaliplatino.&nbsp;<\/span><\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"For_Metastatic_Renal_Cancer\"><\/span>Para el c\u00e1ncer renal metast\u00e1sico<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p><span style=\"font-weight: 400;\">La dosis recomendada de Zirabev en combinaci\u00f3n con interfer\u00f3n alfa es de 10 mg\/kg por v\u00eda intravenosa cada 2 semanas. Zirabev tambi\u00e9n se puede utilizar como monoterapia a una dosis de <\/span><span style=\"font-weight: 400;\">10 mg\/kg cada 2 semanas.&nbsp;<\/span><\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"For_Metastatic_Cervical_Cancer\"><\/span>Para el c\u00e1ncer de cuello uterino metast\u00e1sico<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p><span style=\"font-weight: 400;\">La dosis recomendada es de 15 mg\/kg por v\u00eda intravenosa cada tres semanas en combinaci\u00f3n con topotec\u00e1n y paclitaxel o con cisplatino y paclitaxel.&nbsp;<\/span><\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"For_Ovarian_Cancer\"><\/span>Para el c\u00e1ncer de ovario<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p><span style=\"font-weight: 400;\">La dosis recomendada para pacientes con c\u00e1ncer de ovario se ajusta seg\u00fan su estadio, sensibilidad al tratamiento y resistencia.&nbsp;<\/span><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><span style=\"font-weight: 400;\">Para el c\u00e1ncer en estadio avanzado III\/IV seguido de cirug\u00eda inicial, la dosis de Zirabev en combinaci\u00f3n con paclitaxel y carboplatino es de 15 mg\/kg cada 3 semanas durante un m\u00e1ximo de 6 ciclos, seguida de una dosis \u00fanica (Zirabev solo) de 15 mg\/kg cada 3 semanas durante un total de hasta 22 ciclos.<\/span><\/li>\n<\/ul>\n\n\n\n<ul class=\"wp-block-list\">\n<li><span style=\"font-weight: 400;\">Para la quimioterapia resistente al platino, la dosis de Zirabev en combinaci\u00f3n con topotec\u00e1n, doxorrubicina liposomal pegilada o paclitaxel es de 10 mg\/kg cada 2 semanas. En combinaci\u00f3n solo con topotec\u00e1n, la dosis es de 15 mg\/kg cada 3 semanas.&nbsp;<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Para la quimioterapia sensible al platino, la dosis recomendada de Zirabev en combinaci\u00f3n con carboplatino y paclitaxel es de 15 mg\/kg cada 3 semanas durante 6 a 8 ciclos, seguida de una dosis \u00fanica (Zirabev solo) de 15 mg\/kg cada 3 semanas.<\/span><span style=\"font-weight: 400;\">.<\/span><\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"For_Recurrent_Glioblastoma\"><\/span>Para el glioblastoma recurrente<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p><span style=\"font-weight: 400;\">La dosis recomendada de Zirabev para pacientes con glioblastoma recurrente es de 10 mg\/kg por v\u00eda intravenosa cada dos semanas.&nbsp;<\/span><\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"For_Non-squamous_Non-small_Cell_Lung_Cancer\"><\/span>Para el c\u00e1ncer de pulm\u00f3n de c\u00e9lulas no peque\u00f1as y no escamosas<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p><span style=\"font-weight: 400;\">La dosis recomendada es de 15 mg\/kg por v\u00eda intravenosa cada tres semanas en combinaci\u00f3n con carboplatino y paclitaxel.&nbsp;<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">Zirabev <\/span><span style=\"font-weight: 400;\">puede afectar la cicatrizaci\u00f3n de las heridas. Por ello,<\/span><span style=\"font-weight: 400;\"> i<\/span><span style=\"font-weight: 400;\">Se recomienda no tomar el medicamento antes o despu\u00e9s de la cirug\u00eda durante 28 d\u00edas hasta que las heridas est\u00e9n completamente curadas.&nbsp;<\/span><\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"How_Is_Zirabev_Given\"><\/span>\u00bfC\u00f3mo se administra Zirabev?<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p><span style=\"font-weight: 400;\">Zirabev s\u00f3lo se administra por v\u00eda intravenosa.&nbsp;<\/span><\/p>\n\n\n\n<div  id=\"call-to-action-0042bcc5bcf09a7070bf64c5c63a6504\" style=\"\" class=\"ct_call_to_action\">\n\t<div class=\"container\">\n\t\t<div class=\"block-wrap cta\">\n\t\t\t<div class=\"block-column\">\n\t\t\t\t<div class=\"cta_headings\">\n\t\t\t\t\t\t\t\t\t\t\t<h4 class=\"cta__heading\">\n\t\t\t\t\t\t\tHabla con un especialista\t\t\t\t\t\t<\/h4>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<span class=\"cta_btn\">\n\t\t\t\t\t\t<a href=\"tel:8777780318\">(877) 778-0318<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t<\/div>\n\n\t\t<\/div>\n\t<\/div>\n<\/div>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Is_Zirabev_a_Chemotherapy_Drug\"><\/span>\u00bfEs Zirabev un f\u00e1rmaco de quimioterapia?<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p><span style=\"font-weight: 400;\">No, no es un f\u00e1rmaco de quimioterapia, sino un f\u00e1rmaco inmunoterap\u00e9utico (un anticuerpo). Sin embargo, puede utilizarse en combinaci\u00f3n con...<\/span> <span style=\"font-weight: 400;\">medicamentos de quimioterapia para obtener mejores resultados.<\/span><\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Possible_Side_Effects_of_Zirabev\"><\/span>Posibles efectos secundarios de Zirabev<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"alignright\"><img loading=\"lazy\" decoding=\"async\" width=\"420\" height=\"280\" src=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/02\/Zirabev-side-effects.jpg\" alt=\"Zirabev side effects\" class=\"wp-image-22338\" srcset=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/02\/Zirabev-side-effects.jpg 420w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/02\/Zirabev-side-effects-300x200.jpg 300w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/02\/Zirabev-side-effects-330x220.jpg 330w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/02\/Zirabev-side-effects-86x57.jpg 86w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/02\/Zirabev-side-effects-167x111.jpg 167w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/02\/Zirabev-side-effects-280x187.jpg 280w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/02\/Zirabev-side-effects-370x247.jpg 370w\" sizes=\"auto, (max-width: 420px) 100vw, 420px\" \/><\/figure>\n<\/div>\n\n\n<p><span style=\"font-weight: 400;\">Cada paciente reacciona de forma diferente al recibir infusiones intravenosas de Zirabev. Algunos de los efectos secundarios comunes que pueden experimentar durante o despu\u00e9s de la infusi\u00f3n incluyen:<\/span><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><span style=\"font-weight: 400;\">Dolor de cabeza, dolor de espalda<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Hipertensi\u00f3n<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Inflamaci\u00f3n de la piel y la nariz.<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Cambios en el gusto&nbsp;<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">ojos llorosos<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Sangrado o hemorragia nasal<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Piel seca<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Tos, v\u00f3mitos o n\u00e1useas<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">P\u00e9rdida de apetito<\/span><\/li>\n<\/ul>\n\n\n\n<p><span style=\"font-weight: 400;\">El Zirabev tambi\u00e9n tiene algunos efectos secundarios graves y potencialmente fatales que requieren atenci\u00f3n m\u00e9dica inmediata, como:<\/span><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><span style=\"font-weight: 400;\">Perforaci\u00f3n gastrointestinal&nbsp;<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">S\u00edndrome de encefalopat\u00eda posterior reversible<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Insuficiencia renal<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Complicaciones en la cicatrizaci\u00f3n de heridas<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Reacciones relacionadas con la infusi\u00f3n que causan hipertensi\u00f3n, temblores, dificultad para respirar y dolor en el pecho.&nbsp;<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Insuficiencia card\u00edaca congestiva<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Tromboembolia arterial<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Toxicidad embriofetal<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Accidente cerebrovascular o problema card\u00edaco<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Eventos tromboemb\u00f3licos venosos<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Insuficiencia ov\u00e1rica<\/span><\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Zirabev_Precautions\"><\/span>Precauciones del Zirabev<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p><span style=\"font-weight: 400;\">La terapia con Zirabev no es para todos. Debe consultar con su profesional de la salud antes de tomarla si:<\/span><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><span style=\"font-weight: 400;\">Son <\/span><b>embarazada<\/b><span style=\"font-weight: 400;\">, ya que este medicamento causa toxicidad embriofetal y puede da\u00f1ar al beb\u00e9 nonato.&nbsp;<\/span><\/li>\n<\/ul>\n\n\n\n<ul class=\"wp-block-list\">\n<li><span style=\"font-weight: 400;\">Son <\/span><b>planeando quedar embarazada <\/b><span style=\"font-weight: 400;\">Si est\u00e1 recibiendo tratamiento con Zirabev, entonces debe usar un m\u00e9todo anticonceptivo.&nbsp;<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Son<\/span><b> amamantando o planea amamantar<\/b><span style=\"font-weight: 400;\">Dado que los datos sobre la secreci\u00f3n de Zirabev en la leche materna son limitados, se recomienda evitar Zirabev.&nbsp;<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Tiene antecedentes de hipertensi\u00f3n, insuficiencia card\u00edaca, enfermedad renal y diabetes o se ha sometido a una cirug\u00eda recientemente.<\/span><\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Zirabev_Cost\"><\/span>Costo del Zirabev<span style=\"font-weight: 400;\">&nbsp;<\/span><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p><span style=\"font-weight: 400;\">El costo de Zirabev intravenoso con una concentraci\u00f3n de 100 mg\/4 ml (un vial) es de aproximadamente <\/span><b>$613.40.<\/b><span style=\"font-weight: 400;\"> Para 400 mg\/16 ml (un vial), el costo es de aproximadamente <\/span><b>$2,453.60<\/b><span style=\"font-weight: 400;\">El costo de este medicamento puede variar y depende de la farmacia que visite.&nbsp;<\/span><\/p>","protected":false},"excerpt":{"rendered":"<p>El Zirabev es un f\u00e1rmaco anticancer\u00edgeno cuyo principio activo es el bevacizumab-bvzr. Se utiliza para tratar diversos tipos de c\u00e1ncer y pertenece a la clase de inhibidores del factor de crecimiento endotelial vascular (VEGF) que act\u00faan sobre las prote\u00ednas VEGF y bloquean su actividad.<\/p>","protected":false},"author":21,"featured_media":22337,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"om_disable_all_campaigns":false,"_uag_custom_page_level_css":"","footnotes":""},"categories":[13],"tags":[27],"class_list":["post-22336","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-cancer","tag-dr-abdelaziz-alsamarah"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Zirabev: What Is It and How Does It Work? - AmeriPharma\u00ae Specialty Care<\/title>\n<meta name=\"description\" content=\"Learn about the anticancer drug, Zirabev. Topics include how it works, what it treats, dosing information and side effects.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ameripharmaspecialty.com\/es\/cancer\/zirabev\/\" \/>\n<meta property=\"og:locale\" content=\"es_MX\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Zirabev: What Is It and How Does It Work? - AmeriPharma\u00ae Specialty Care\" \/>\n<meta property=\"og:description\" content=\"Learn about the anticancer drug, Zirabev. Topics include how it works, what it treats, dosing information and side effects.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ameripharmaspecialty.com\/es\/cancer\/zirabev\/\" \/>\n<meta property=\"og:site_name\" content=\"AmeriPharma\u00ae Specialty Care\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/ameripharma\/\" \/>\n<meta property=\"article:published_time\" content=\"2023-02-16T18:17:29+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-03-20T21:32:13+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/02\/Zirabev-patient.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"853\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Dr. Abdelaziz Alsamarah, PharmD, MSPS, BCSCP\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Dr. Abdelaziz Alsamarah, PharmD, MSPS, BCSCP\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"6 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/cancer\\\/zirabev\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/cancer\\\/zirabev\\\/\"},\"author\":{\"name\":\"Dr. Abdelaziz Alsamarah, PharmD, MSPS, BCSCP\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#\\\/schema\\\/person\\\/2f73858b25c20aa6bf5b731fd4e593c4\"},\"headline\":\"Zirabev: What Is It and How Does It Work?\",\"datePublished\":\"2023-02-16T18:17:29+00:00\",\"dateModified\":\"2026-03-20T21:32:13+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/cancer\\\/zirabev\\\/\"},\"wordCount\":1290,\"publisher\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/cancer\\\/zirabev\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2023\\\/02\\\/Zirabev-patient.jpg\",\"keywords\":[\"Dr. Abdelaziz Alsamarah\"],\"articleSection\":[\"Cancer\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/cancer\\\/zirabev\\\/\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/cancer\\\/zirabev\\\/\",\"name\":\"Zirabev: What Is It and How Does It Work? - AmeriPharma\u00ae Specialty Care\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/cancer\\\/zirabev\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/cancer\\\/zirabev\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2023\\\/02\\\/Zirabev-patient.jpg\",\"datePublished\":\"2023-02-16T18:17:29+00:00\",\"dateModified\":\"2026-03-20T21:32:13+00:00\",\"description\":\"Learn about the anticancer drug, Zirabev. Topics include how it works, what it treats, dosing information and side effects.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/cancer\\\/zirabev\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/cancer\\\/zirabev\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/cancer\\\/zirabev\\\/#primaryimage\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2023\\\/02\\\/Zirabev-patient.jpg\",\"contentUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2023\\\/02\\\/Zirabev-patient.jpg\",\"width\":1280,\"height\":853,\"caption\":\"Zirabev patient\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/cancer\\\/zirabev\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Zirabev: What Is It and How Does It Work?\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#website\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/\",\"name\":\"AmeriPharma\u00ae Specialty Care\",\"description\":\"Specialty Care by AmeriPharma\",\"publisher\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#organization\",\"name\":\"Ameripharma Specialty Care\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/specialty-care-logo-large-square.png\",\"contentUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/specialty-care-logo-large-square.png\",\"width\":400,\"height\":400,\"caption\":\"Ameripharma Specialty Care\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/ameripharma\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#\\\/schema\\\/person\\\/2f73858b25c20aa6bf5b731fd4e593c4\",\"name\":\"Dr. Abdelaziz Alsamarah, PharmD, MSPS, BCSCP\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8671a91ecba97f36a7f5e6492c279b433d2a9c2ac61cf480154cdd3c51b5fe3d?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8671a91ecba97f36a7f5e6492c279b433d2a9c2ac61cf480154cdd3c51b5fe3d?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8671a91ecba97f36a7f5e6492c279b433d2a9c2ac61cf480154cdd3c51b5fe3d?s=96&d=mm&r=g\",\"caption\":\"Dr. Abdelaziz Alsamarah, PharmD, MSPS, BCSCP\"},\"description\":\"Dr. Alsamarah received his PharmD degree from the University of Jordan in 2011. In pursuit of higher education, he joined Western University of Health Sciences, Pomona, CA in 2014 and received a masters in pharmaceutical sciences with major in Computer-Aided Drug Design (CADD). He has authored and co-authored several publications in major scientific journals. After graduation, Dr. Alsamarah worked in various pharmacy settings before he found his passion in managing patients on IV infusions. His specialty areas include: Infectious diseases, nutrition support, and monoclonal antibodies. In his free time, he likes boxing, biking, and painting with his three kids.\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/author\\\/abdelaziz\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Zirabev: \u00bfQu\u00e9 es y c\u00f3mo funciona? - AmeriPharma\u00ae Cuidado especializado","description":"Aprenda sobre el medicamento contra el c\u00e1ncer Zirabev. Los temas incluyen c\u00f3mo funciona, qu\u00e9 trata, informaci\u00f3n sobre la dosificaci\u00f3n y efectos secundarios.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ameripharmaspecialty.com\/es\/cancer\/zirabev\/","og_locale":"es_MX","og_type":"article","og_title":"Zirabev: What Is It and How Does It Work? - AmeriPharma\u00ae Specialty Care","og_description":"Learn about the anticancer drug, Zirabev. Topics include how it works, what it treats, dosing information and side effects.","og_url":"https:\/\/ameripharmaspecialty.com\/es\/cancer\/zirabev\/","og_site_name":"AmeriPharma\u00ae Specialty Care","article_publisher":"https:\/\/www.facebook.com\/ameripharma\/","article_published_time":"2023-02-16T18:17:29+00:00","article_modified_time":"2026-03-20T21:32:13+00:00","og_image":[{"width":1280,"height":853,"url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/02\/Zirabev-patient.jpg","type":"image\/jpeg"}],"author":"Dr. Abdelaziz Alsamarah, PharmD, MSPS, BCSCP","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Dr. Abdelaziz Alsamarah, PharmD, MSPS, BCSCP","Est. reading time":"6 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ameripharmaspecialty.com\/zh\/cancer\/zirabev\/#article","isPartOf":{"@id":"https:\/\/ameripharmaspecialty.com\/zh\/cancer\/zirabev\/"},"author":{"name":"Dr. Abdelaziz Alsamarah, PharmD, MSPS, BCSCP","@id":"https:\/\/ameripharmaspecialty.com\/#\/schema\/person\/2f73858b25c20aa6bf5b731fd4e593c4"},"headline":"Zirabev: What Is It and How Does It Work?","datePublished":"2023-02-16T18:17:29+00:00","dateModified":"2026-03-20T21:32:13+00:00","mainEntityOfPage":{"@id":"https:\/\/ameripharmaspecialty.com\/zh\/cancer\/zirabev\/"},"wordCount":1290,"publisher":{"@id":"https:\/\/ameripharmaspecialty.com\/#organization"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/zh\/cancer\/zirabev\/#primaryimage"},"thumbnailUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/02\/Zirabev-patient.jpg","keywords":["Dr. Abdelaziz Alsamarah"],"articleSection":["Cancer"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/ameripharmaspecialty.com\/zh\/cancer\/zirabev\/","url":"https:\/\/ameripharmaspecialty.com\/zh\/cancer\/zirabev\/","name":"Zirabev: \u00bfQu\u00e9 es y c\u00f3mo funciona? - AmeriPharma\u00ae Cuidado especializado","isPartOf":{"@id":"https:\/\/ameripharmaspecialty.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ameripharmaspecialty.com\/zh\/cancer\/zirabev\/#primaryimage"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/zh\/cancer\/zirabev\/#primaryimage"},"thumbnailUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/02\/Zirabev-patient.jpg","datePublished":"2023-02-16T18:17:29+00:00","dateModified":"2026-03-20T21:32:13+00:00","description":"Aprenda sobre el medicamento contra el c\u00e1ncer Zirabev. Los temas incluyen c\u00f3mo funciona, qu\u00e9 trata, informaci\u00f3n sobre la dosificaci\u00f3n y efectos secundarios.","breadcrumb":{"@id":"https:\/\/ameripharmaspecialty.com\/zh\/cancer\/zirabev\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ameripharmaspecialty.com\/zh\/cancer\/zirabev\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/ameripharmaspecialty.com\/zh\/cancer\/zirabev\/#primaryimage","url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/02\/Zirabev-patient.jpg","contentUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/02\/Zirabev-patient.jpg","width":1280,"height":853,"caption":"Zirabev patient"},{"@type":"BreadcrumbList","@id":"https:\/\/ameripharmaspecialty.com\/zh\/cancer\/zirabev\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ameripharmaspecialty.com\/"},{"@type":"ListItem","position":2,"name":"Zirabev: What Is It and How Does It Work?"}]},{"@type":"WebSite","@id":"https:\/\/ameripharmaspecialty.com\/#website","url":"https:\/\/ameripharmaspecialty.com\/","name":"Cuidado especializado AmeriPharma\u00ae","description":"Atenci\u00f3n especializada por AmeriPharma","publisher":{"@id":"https:\/\/ameripharmaspecialty.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ameripharmaspecialty.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/ameripharmaspecialty.com\/#organization","name":"Atenci\u00f3n especializada de Ameripharma","url":"https:\/\/ameripharmaspecialty.com\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/ameripharmaspecialty.com\/#\/schema\/logo\/image\/","url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/specialty-care-logo-large-square.png","contentUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/specialty-care-logo-large-square.png","width":400,"height":400,"caption":"Ameripharma Specialty Care"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/ameripharma\/"]},{"@type":"Person","@id":"https:\/\/ameripharmaspecialty.com\/#\/schema\/person\/2f73858b25c20aa6bf5b731fd4e593c4","name":"Dr. Abdelaziz Alsamarah, PharmD, MSPS, BCSCP","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/8671a91ecba97f36a7f5e6492c279b433d2a9c2ac61cf480154cdd3c51b5fe3d?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/8671a91ecba97f36a7f5e6492c279b433d2a9c2ac61cf480154cdd3c51b5fe3d?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/8671a91ecba97f36a7f5e6492c279b433d2a9c2ac61cf480154cdd3c51b5fe3d?s=96&d=mm&r=g","caption":"Dr. Abdelaziz Alsamarah, PharmD, MSPS, BCSCP"},"description":"El Dr. Alsamarah obtuvo su doctorado en farmacia en la Universidad de Jordania en 2011. Para continuar sus estudios superiores, se incorpor\u00f3 a la Universidad Occidental de Ciencias de la Salud, Pomona, California, en 2014 y obtuvo una maestr\u00eda en ciencias farmac\u00e9uticas con especializaci\u00f3n en Dise\u00f1o de F\u00e1rmacos Asistido por Computadora (CADD). Es autor y coautor de varias publicaciones en importantes revistas cient\u00edficas. Tras graduarse, el Dr. Alsamarah trabaj\u00f3 en diversos entornos farmac\u00e9uticos antes de descubrir su pasi\u00f3n por el manejo de pacientes con infusiones intravenosas. Sus \u00e1reas de especialidad incluyen enfermedades infecciosas, apoyo nutricional y anticuerpos monoclonales. En su tiempo libre, le gusta boxear, montar en bicicleta y pintar con sus tres hijos.","url":"https:\/\/ameripharmaspecialty.com\/es\/author\/abdelaziz\/"}]}},"uagb_featured_image_src":{"full":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/02\/Zirabev-patient.jpg",1280,853,false],"thumbnail":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/02\/Zirabev-patient-150x150.jpg",150,150,true],"medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/02\/Zirabev-patient-300x200.jpg",300,200,true],"medium_large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/02\/Zirabev-patient-768x512.jpg",768,512,true],"large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/02\/Zirabev-patient-1024x682.jpg",1024,682,true],"1536x1536":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/02\/Zirabev-patient.jpg",1280,853,false],"2048x2048":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/02\/Zirabev-patient.jpg",1280,853,false],"trp-custom-language-flag":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/02\/Zirabev-patient.jpg",18,12,false],"block-image-html-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/02\/Zirabev-patient.jpg",600,400,false],"ct-gallery":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/02\/Zirabev-patient-330x220.jpg",330,220,true],"ct-section-header":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/02\/Zirabev-patient-1146x380.jpg",1146,380,true],"ct-thumb":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/02\/Zirabev-patient-86x57.jpg",86,57,true],"ct-thumb-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/02\/Zirabev-patient-167x111.jpg",167,111,true],"ct-small":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/02\/Zirabev-patient-280x187.jpg",280,187,true],"ct-medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/02\/Zirabev-patient-370x247.jpg",370,247,true],"ct-xmedium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/02\/Zirabev-patient-960x640.jpg",960,640,true],"ct-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/02\/Zirabev-patient.jpg",1280,853,false]},"uagb_author_info":{"display_name":"Dr. Abdelaziz Alsamarah, PharmD, MSPS, BCSCP","author_link":"https:\/\/ameripharmaspecialty.com\/es\/author\/abdelaziz\/"},"uagb_comment_info":0,"uagb_excerpt":"Zirabev is an anticancer drug with an active component, \"bevacizumab-bvzr.\" It is used to treat several types of cancer and belongs to the class of vascular endothelial growth factor (VEGF) inhibitors that targets VEGF proteins and blocks their activity.","rttpg_featured_image_url":{"full":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/02\/Zirabev-patient.jpg",1280,853,false],"landscape":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/02\/Zirabev-patient.jpg",1280,853,false],"portraits":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/02\/Zirabev-patient.jpg",1280,853,false],"thumbnail":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/02\/Zirabev-patient-150x150.jpg",150,150,true],"medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/02\/Zirabev-patient-300x200.jpg",300,200,true],"large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/02\/Zirabev-patient-1024x682.jpg",1024,682,true],"1536x1536":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/02\/Zirabev-patient.jpg",1280,853,false],"2048x2048":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/02\/Zirabev-patient.jpg",1280,853,false],"trp-custom-language-flag":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/02\/Zirabev-patient.jpg",18,12,false],"block-image-html-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/02\/Zirabev-patient.jpg",600,400,false],"ct-gallery":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/02\/Zirabev-patient-330x220.jpg",330,220,true],"ct-section-header":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/02\/Zirabev-patient-1146x380.jpg",1146,380,true],"ct-thumb":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/02\/Zirabev-patient-86x57.jpg",86,57,true],"ct-thumb-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/02\/Zirabev-patient-167x111.jpg",167,111,true],"ct-small":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/02\/Zirabev-patient-280x187.jpg",280,187,true],"ct-medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/02\/Zirabev-patient-370x247.jpg",370,247,true],"ct-xmedium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/02\/Zirabev-patient-960x640.jpg",960,640,true],"ct-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/02\/Zirabev-patient.jpg",1280,853,false]},"rttpg_author":{"display_name":"Dr. Abdelaziz Alsamarah, PharmD, MSPS, BCSCP","author_link":"https:\/\/ameripharmaspecialty.com\/es\/author\/abdelaziz\/"},"rttpg_comment":0,"rttpg_category":"<a href=\"https:\/\/ameripharmaspecialty.com\/es\/category\/cancer\/\" rel=\"category tag\">Cancer<\/a>","rttpg_excerpt":"Zirabev is an anticancer drug with an active component, \"bevacizumab-bvzr.\" It is used to treat several types of cancer and belongs to the class of vascular endothelial growth factor (VEGF) inhibitors that targets VEGF proteins and blocks their activity.","_links":{"self":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/posts\/22336","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/users\/21"}],"replies":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/comments?post=22336"}],"version-history":[{"count":0,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/posts\/22336\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/media\/22337"}],"wp:attachment":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/media?parent=22336"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/categories?post=22336"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/tags?post=22336"}],"curies":[{"name":"gracias","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}